These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9741046)

  • 21. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss.
    Breum L; Møller SE; Andersen T; Astrup A
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):147-53. PubMed ID: 8646251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotoninergic system: therapeutic implications in obesity.
    Finer N
    Acta Clin Belg Suppl; 1992; 14():47-51. PubMed ID: 1604961
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
    Héraïef E
    Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In memory of dexfenfluramine: R.I.P.
    Carruba MO; Nisoli E
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1193. PubMed ID: 9426390
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
    de Bont PA; van den Berg DP; van der Vleugel BM; de Roos C; de Jongh A; van der Gaag M; van Minnen AM
    Psychol Med; 2016 Aug; 46(11):2411-21. PubMed ID: 27297048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of drugs used to treat obesity on the autonomic nervous system.
    Hirsch J; Mackintosh RM; Aronne LJ
    Obes Res; 2000 May; 8(3):227-33. PubMed ID: 10832765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New treatment for obesity: dexfenfluramine (Redux).
    Bihm B
    Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
    [No Abstract]   [Full Text] [Related]  

  • 28. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatometric and hormonal effects of dexfenfluramine.
    Sonka J; Marek J; Svacina S; Sucharda P; Stĕpán J
    Sb Lek; 1995; 96(4):299-301. PubMed ID: 8711372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Image of the month. A case of aortic regurgitation association with dexfenfluramine].
    Bouffioux L; Radermecker MA; De Leval L; D'Orio V; Limet R
    Rev Med Liege; 2009 Sep; 64(9):432-3. PubMed ID: 19947311
    [No Abstract]   [Full Text] [Related]  

  • 31. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of binge-eating disorder with topiramate: a clinical case series.
    Shapira NA; Goldsmith TD; McElroy SL
    J Clin Psychiatry; 2000 May; 61(5):368-72. PubMed ID: 10847312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexfenfluramine.
    Spollett G
    Lippincotts Prim Care Pract; 1997; 1(3):320-3. PubMed ID: 9238953
    [No Abstract]   [Full Text] [Related]  

  • 34. Dexfenfluramine hydrochloride: an anorexigenic agent.
    Bever KA; Perry PJ
    Am J Health Syst Pharm; 1997 Sep; 54(18):2059-72. PubMed ID: 9377205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.
    Weissman NJ; Tighe JF; Gottdiener JS; Gwynne JT
    N Engl J Med; 1998 Sep; 339(11):725-32. PubMed ID: 9731088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Late onset schizophrenias: a case of chronic hallucinatory psychosis].
    Fabregat Navarro V; Lozano Suárez M; Díaz Marsá M; Padín Calo J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):353-7. PubMed ID: 9054206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders.
    Goghari VM; Harrow M; Grossman LS; Rosen C
    Psychol Med; 2013 Jun; 43(6):1151-60. PubMed ID: 23034091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
    Ditschuneit HH; Flechtner-Mors M; Dolderer M; Fulda U; Ditschuneit H
    Horm Metab Res; 1993 Nov; 25(11):573-8. PubMed ID: 8288160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-year follow-up of drug abusers with acute or chronic psychosis.
    Perkins KA; Simpson JC; Tsuang MT
    Hosp Community Psychiatry; 1986 May; 37(5):481-4. PubMed ID: 3699715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.